Updated Results from a Phase I/II Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Richter's Syndrome (RS)Christine E. Ryan, Matthew S. Davids, Jacob D. Soumerai et al.|Blood|2022Cited by 8
A Phase 2 Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Richter's Syndrome (RS)Jennifer L. Crombie, Matthew S. Davids, Christine E. Ryan et al.|Blood|2024Cited by 6
A phase 1/2 study of duvelisib plus venetoclax in patients with relapsed/refractory CLL/SLL or Richter transformationJennifer L. Crombie, Matthew S. Davids, Christine E. Ryan et al.|Blood Advances|2026Cited by 0